Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term effects of Glepaglutide on intestinal absorption and safety in patients with Short Bowel Syndrome; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glepaglutide (glepaglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-11-22